Coronavirus Update With CDC Director Rochelle Walensky
Incoming Centers for Disease Control and Prevention (CDC) Director Rochelle P. Walensky, MD, MPH, returns to JAMA's Q&A series to discuss her vision and priorities for the agency and changes in its pandemic response strategies, when she takes the reins on January 20. Recorded January 19, 2021. Related Article(s): All-Cause Excess Mortality and COVID-19–Related Mortality Among US Adults Aged 25-44 Years, March-July 2020 (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - January 21, 2021 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Coronavirus Vaccine Update with Paul Offit and Robert Wachter
To get more vaccine to more people more efficiently, UCSF School of Medicine's Robert M. Wachter, MD, recently urged giving a single dose now and deferring the second dose until more vaccine is available. Paul A. Offit, MD, of The Children's Hospital of Philadelphia, disagrees. The two discuss the pros and the cons of the plan and alternative responses to road bumps in the US vaccine rollout, on JAMA's live Q&A series. Recorded January 19, 2021. Related Article: Developing a SARS-CoV-2 Vaccine at Warp Speed (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - January 21, 2021 Category: General Medicine Authors: JAMA Network Source Type: podcasts
USPSTF Recommendation: Tobacco Cessation in Adults
Interview with Michael Silverstein, MD, MPH, USPSTF member and coauthor of USPSTF Recommendation: Tobacco Cessation in Adults (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - January 19, 2021 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Public Health Messaging in an Era of Social Media
Interview with Raina M. Merchant, MD, author of Public Health Messaging in an Era of Social Media (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - January 19, 2021 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Thrombolysis Before Thrombectomy for Stroke
Intravenous thrombolysis (IVT) and endovascular thrombectomy (EVT) both improve outcomes for patients with acute ischemic stroke. Jeffrey L. Saver, MD, director of UCLA’s Comprehensive Stroke and Vascular Neurology Program and a JAMA Associate Editor, discusses 2 randomized trials comparing outcomes for stroke patients treated with IVT prior to EVT vs EVT alone. Related Article: Intravenous Thrombolysis Before Endovascular Thrombectomy for Acute Ischemic Stroke (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - January 19, 2021 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Coronavirus Critical Care Update With Lennie Derde and Christopher Seymour
The COVID-19 pandemic has prompted scientists to use adaptive research designs to evaluate potential treatments simultaneously and efficiently, increasing the likelihood that patients will receive treatments most likely to be effective for them. Lennie Derde, MD, of University Medical Center Utrecht in the Netherlands and JAMA Associate Editor Christopher W. Seymour, MD, of University of Pittsburgh Medical Center join JAMA's Q&A series to discuss the latest in critical care management of COVID-19 patients and emerging treatment strategies and therapies. Recorded January 13, 2021. Related Article(s): Sensible Medicine-Optim...
Source: JAMA Author Interviews - January 15, 2021 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Coronavirus Vaccine Update With Arnold S. Monto, MD
Arnold S. Monto, MD, chaired the US Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee (VRBPAC) meetings in December that led to Emergency Use Authorization (EUA) of the Pfizer/BioNTech and Moderna vaccines. He joins JAMA's Q&A series from the University of Michigan School of Public Health to discuss experience to date with the 2 products and what's next in vaccine development. Recorded January 11, 2021. Related Article(s): Experts Discuss COVID-19: Vaccine Allocation, Placebo Groups, and More (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - January 14, 2021 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Diversifying Medical Education
Increasing the number of physicians who are Black, Hispanic/Latinx, and Indigenous benefits everyone in the US, but it cannot be the sole responsibility of historically Black colleges and universities (HBCUs). Valerie Montgomery Rice, MD, president and dean of Morehouse School of Medicine (MSM), and Clyde W. Yancy, MD, of Northwestern Medicine, join JAMA Editor in Chief Howard Bauchner, MD, to discuss options for developing training pipelines of underrepresented minority health science students, and how academic medicine can make racial justice a part of its work and mission. Recorded January 5, 2021. Related Article: Acad...
Source: JAMA Author Interviews - January 8, 2021 Category: General Medicine Authors: JAMA Network Source Type: podcasts
To Err Is Human: 20 Years of Health Care Quality
The National Academy of Medicine's 2000 report "To Err Is Human" launched the health care quality movement in the US. Victor Dzau, MD, president of the National Academy of Medicine, and Don Berwick, MD, MPP, from the Institute for Healthcare Improvement, discuss progress to date in advancing quality and prospects for improving outcomes and reducing harms, errors, and cost in the next 20 years. Recorded December 22, 2020. Related Article(s): Two Decades Since To Err Is Human (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - December 29, 2020 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Digital Health —The Need to Assess Benefits, Risks, and Value
Interview with Geoffrey S. Ginsburg, MD, PhD, author of Digital Health—The Need to Assess Benefits, Risks, and Value (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - December 28, 2020 Category: General Medicine Authors: JAMA Network Source Type: podcasts
COVID-19 Vaccines and Herd Immunity
With coronavirus vaccines now available, what are the timeline and prospects for "herd immunity" and return to a new normal? Marc Lipsitch, DPhil, of Harvard T.H. Chan School of Public Health returns to JAMA's Q&A series with Paul D. Biddinger, MD, director of Massachusetts General Hospital's Center for Disaster Medicine, to discuss. Recorded December 17, 2020. Related Article: The Ethics of Continuing Placebo in SARS-CoV-2 Vaccine Trials (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - December 21, 2020 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Coronavirus Vaccine FDA Update
Peter W. Marks, MD, PhD, and Stephen M. Hahn, MD, return to JAMA's Q&A series to discuss the Pfizer/BioNTech and Moderna vaccines: the data, the weekend's EUA designation (Pfizer/BioNTech), and the process for future full licensure and postmarketing safety surveillance. Dr Marks directs the US FDA's Center for Biologics Evaluation and Research (CBER). Dr Hahn is commissioner of the US Food and Drug Administration. Recorded December 14, 2020. Related Article(s): Behaviorally Informed Strategies for a National COVID-19 Vaccine Promotion Program (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - December 16, 2020 Category: General Medicine Authors: JAMA Network Source Type: podcasts
USPSTF Recommendation: Screening for Hepatitis B Virus Infection in Adolescents and Adults
Interview with Chyke A. Doubeni, MD, MPH, USPSTF member and coauthor of USPSTF Recommendation: Screening for Hepatitis B Virus Infection in Adolescents and Adults (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - December 15, 2020 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Trust in Health Care in the Time of COVID-19
Interview with David W. Baker, MD, MPH, author of Trust in Health Care in the Time of COVID-19 (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - December 15, 2020 Category: General Medicine Authors: JAMA Network Source Type: podcasts
Coronavirus Vaccine Update With Anthony Fauci
Anthony S. Fauci, MD, returns to JAMA's Q&A series to discuss the Pfizer/BioNTech and Moderna vaccines: the public data, deliberations at Thursday's FDA Advisory Committee meeting, and prospects for an agency Emergency Use Authorization designation, licensure, and rollout. Recorded December 11, 2020. Related Article(s): Coronavirus Infections—More Than Just the Common Cold (Source: JAMA Author Interviews)
Source: JAMA Author Interviews - December 14, 2020 Category: General Medicine Authors: JAMA Network Source Type: podcasts
